Ravi Vemulapalli, MD
Gastroenterology · Clive, IANPI 1992763122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 26.0% of the total. Reporting peaked in 2022 at $1,252 and has fallen 75.0% since, to $313 in 2025.
Across 186 payments — averaging $20.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$586
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$295
- Madrigal Pharmaceuticals$283
- Janssen Scientific Affairs, LLC$248
- Takeda Pharmaceuticals U.S.A., Inc.$209
- plus $1K from 21 others
Across 1 payment — averaging $1250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1K
What the payments were for
- Food & beverage$3,874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $1,008 |
| Johnson & Johnson(2 entities) | 38 | $586 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $295 |
| Madrigal Pharmaceuticals | 2 | $283 |
| Janssen Scientific Affairs, LLC | 2 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $209 |
| Phathom Pharmaceuticals, Inc. | 3 | $142 |
| Regeneron Healthcare Solutions, Inc. | 2 | $139 |
| Pfizer | 9 | $134 |
| Merck | 7 | $127 |
| E.r. Squibb & Sons, L.L.C. | 1 | $115 |
| Bristol Myers Squibb | 6 | $98 |
| UCB, Inc. | 4 | $58 |
| Lilly USA, LLC | 2 | $57 |
| Organon | 3 | $54 |
| Sanofi | 3 | $49 |
| Ardelyx, Inc. | 2 | $38 |
| Alcresta Therapeutics, Inc. | 1 | $31 |
| Boston Scientific | 1 | $30 |
| Intercept Pharmaceuticals, Inc. | 2 | $27 |
| Amgen | 1 | $26 |
| QOL Medical, LLC | 1 | $24 |
| Gilead | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Bayer | 1 | $20 |
| Biogen | 1 | $18 |
| VBI Vaccine (delaware) Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,874 in reported general payments places this provider in the 80th percentile of 113 gastroenterology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 24 | $9,786 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 146 | $9,385 |
| Sucralfate | 39 | $7,270 |
| Ursodiol | 15 | $3,907 |
| Pantoprazole Sodium | 164 | $1,790 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 39 | $875 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 48 | $800 |
| Balsalazide Disodium | 11 | $751 |
| Sulfasalazine | 13 | $395 |
| Omeprazole | 29 | $368 |
| Dicyclomine Hcl | 33 | $361 |
| LoperamideLoperamide Hcl | 37 | $283 |
| Azathioprine | 17 | $206 |
| Ondansetron OdtOndansetron | 96 | $121 |
| Propranolol Hcl | 20 | $119 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Clive
- Nagendra MyneniClive$66K
- Bernard LemanClive$12K
- Archana VermaClive$6K
- Christopher MulderClive$6K
- Benjamin PottebaumClive$6K
- Amol AgarwalClive$6K
- Tercio LopesClive$5K
- Thomas MartinClive$2K
- Rajalakshmi IyerClive$2K
- Jeffrey BrannenClive$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.